Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
IL0010941198
Pharmaceuticals
| Market Cap | 1.45B 0 474M 411M 388M 352M 660M 45.47B 665M 4.63B 1.79B 23.07B 1.78B 1.74B 73.33B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.45B 0 474M 411M 388M 352M 660M 45.47B 665M 4.63B 1.79B 23.07B 1.78B 1.74B 73.33B | EV / Sales 2026 * |
2.39x | EV / Sales 2027 * | 2.15x |
| Free-Float |
54.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | -0.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -1.04% | - | - | 474M | |
| +1.57% | -4.11% | +41.74% | -4.64% | 79.26B | |
| +1.89% | +0.78% | +523.95% | +30.03% | 58.56B | |
| +1.57% | -0.31% | -14.78% | -34.90% | 58.62B | |
| +0.35% | -3.14% | -11.03% | +26.34% | 48.75B | |
| 0.00% | +1.74% | +2.43% | +150.00% | 46.32B | |
| +0.10% | -1.57% | +50.05% | -15.20% | 32.12B | |
| +0.59% | -3.60% | +47.04% | +92.49% | 24.77B | |
| -1.96% | -5.34% | -0.78% | +141.96% | 21.5B | |
| -1.07% | -2.63% | +63.00% | +98.48% | 15.97B | |
| Average | +0.05% | -1.72% | +77.96% | +53.84% | 42.87B | |
| Weighted average by Cap. | +0.49% | -1.65% | +94.50% | +36.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 606M 0 199M 172M 163M 147M 277M 19.06B 279M 1.94B 748M 9.67B 747M 730M 30.73B | 673M 0 221M 191M 181M 164M 307M 21.18B 310M 2.16B 831M 10.74B 830M 811M 34.15B |
| Net income | 84.8M 0 27.83M 24.11M 22.75M 20.64M 38.72M 2.67B 39.01M 272M 105M 1.35B 105M 102M 4.3B | 104M 0 34.17M 29.61M 27.94M 25.35M 47.55M 3.27B 47.89M 334M 129M 1.66B 128M 126M 5.28B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
